OPEN EVIDENCE

Their core work

Open Evidence is a Barcelona-based research consultancy specializing in evidence-based policy analysis and impact evaluation, with a strong focus on digital health and active ageing. They provide socio-economic analysis, behavioural research, and evaluation services within large EU-funded consortia — translating complex health and technology interventions into actionable policy insights. Their work spans from assessing digital health platforms and patient adherence models to analysing science education methods and pandemic response tools.

What they specialise in

How they've shifted over time

In their early H2020 period (2015–2018), Open Evidence worked across diverse topics — digital policy, STEM education, and early active ageing support — acting as a generalist evaluation partner. From 2019 onward, they sharply concentrated on digital health: patient adherence, personalised medicine, health data standards, and explainable AI for clinical use. This pivot shows a deliberate move from broad innovation consulting toward becoming a specialist in health technology impact assessment and behavioural health research.

Open Evidence is deepening into health data governance, AI explainability in clinical settings, and behavioural models for treatment adherence — positioning itself as a go-to evaluation partner for health-tech consortia.

How they like to work

Open Evidence operates exclusively as a participant, never as coordinator, which suggests they serve a specialist support function — likely providing evaluation, impact assessment, or socio-economic analysis within larger teams. With 190 unique partners across 27 countries in 11 projects, they work in large, diverse consortia and do not appear tied to a fixed set of partners. This makes them an adaptable, low-friction partner to integrate into new consortia.

With 190 unique consortium partners across 27 countries, Open Evidence has a remarkably wide European network for an SME of its size. Their connections span health, digital, and social innovation ecosystems across virtually all EU member states.

What sets them apart

Open Evidence fills a specific niche: they are a private research SME that brings rigorous socio-economic and behavioural analysis to technology-heavy health consortia. While many partners build the technology, Open Evidence evaluates whether it actually works and why users adopt or reject it. For consortium builders, they offer a ready-made evaluation and impact assessment capability without the overhead of a large research institute.

Highlights from their portfolio

• GATEKEEPER
  Their largest single grant (EUR 331K) in a major smart living demonstrator targeting health and social risk detection across multiple pilot sites.
• BEAMER
  Focuses on behavioural adherence modelling — directly aligned with their emerging specialisation in patient behaviour and health outcomes cost-effectiveness.
• KATY
  Marks their entry into explainable AI for clinical knowledge, signalling expansion from pure evaluation into AI-driven health intelligence.